Life Saving Drugs Program resources – Mucopolysaccharidosis type VI (MPS VI)

A collection of resources for health professionals to help people with mucopolysaccharidosis type VI (MPS VI) access galsulfase (Naglazyme®) under the Life Saving Drugs Program (LSDP).

This collection contains guidelines, forms and documents related to accessing galsulfase (Naglazyme®) under the LSDP. Click to view the Naglazyme® product information on the Therapeutic Goods Administration website.

Guidelines

Forms

Medicines review documents

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Collection
Audience:
Health sector

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.